Canada - Lipid Modifying Medicine Use
Since 2014, Canada Lipid Modifying Medicine Use grew 5% year on year. With 128.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was ranked number 9 among other countries in Lipid Modifying Medicine Use. Canada is overtaken by Netherlands, which was number 8 at 136.2 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Sweden at 127.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Denmark lead the ranking with 159.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, +3.5% compared to 2018. United Kingdom, Belgium and Norway respectively ranked number 2, 3 and 4 in this ranking. Lithuania witnessed the best average annual growth at +15% per year, while Slovakia was the worst growing country at -7% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 128.50 |
| 2018 | 126.00 |
| 2017 | 120.50 |
| 2016 | 115.80 |
| 2015 | 103.40 |
How does Canada rank in Lipid Modifying Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Denmark
|
160 | 2019 | +3.5 % | +3.8 % | View data | |
| 2 |
#2
United Kingdom
|
153 | 2019 | +1.7 % | +2.3 % | View data | |
| 8 |
#8
Netherlands
|
136 | 2019 | +2.6 % | +3.2 % | View data | |
| 9 |
#9
Canada
|
129 | 2019 | +2.0 % | +5.0 % | View data | |
| 10 |
#10
Sweden
|
127 | 2019 | +2.4 % | +6.7 % | View data | |